• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT ACT CELITE CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT ACT CELITE CARTRIDGE Back to Search Results
Catalog Number 03P86-25
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code Chest Pain (1776)
Date of Event 04/23/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event or Problem Description
On (b)(6) 2021, abbott point of care was contacted by a customer regarding act celite cartridges that yielded discrepant results on an (b)(6) year old male patient with chest pain.There was no additional patient information available at the time of this report.Return product is not available for investigation.(b)(6).The reporting decision was based on the limited information available that suggests the product was not performing within the variability of the assay.Results on samples a, b & c & d showed consistent with heparin doses.However, the last result which was a repeat of sample d show time jumping to >1000 secs on the same sample.The customer states the patient did not have negative impact.But a near miss for over heparinization.The increase could not be explained.The investigation is underway.
 
Additional Manufacturer Narrative
Apoc incident: # (b)(4).The investigation was completed on 28-jun-2021.A review of the device history record confirmed that the cartridge lot passed release specifications.A deficiency has been identified for act celite cartridge lot r21058a.Retained cartridge testing does not meet the acceptance criterion for points outside total allowable error outlined in appendix 1 of q04.01.003 rev.Af (product complaint level 2 and level 3 investigation procedure),.Quality record (b)(4) has been initiated to address root cause.
 
Event or Problem Description
Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT ACT CELITE CARTRIDGE
Common Device Name
ACT CELITE CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
MDR Report Key11807199
Report Number2245578-2021-00042
Device Sequence Number17074135
Product Code JBP
UDI-Device Identifier10054749000149
UDI-Public10054749000149
Combination Product (Y/N)N
Initial Reporter StateNH
Initial Reporter CountryUS
PMA/510(K) Number
K992571
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/26/2021
Device Catalogue Number03P86-25
Device Lot NumberR21058A
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 04/28/2021
Supplement Date Received by Manufacturer06/28/2021
Initial Report FDA Received Date05/11/2021
Supplement Report FDA Received Date07/08/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age67 YR
-
-